Home > Insider Trading > Filing (0001104659-11-018940)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1274644	Tranzyme Inc	TZYM	Pharmaceutical Preparations (2834)	631192270

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1050045	Anthony Tamer	C/O H.i.g. Capital 1450 Brickell Avenue, 31St Floor Miami FL 33131	No	No	Yes	No
1050046	Sami Mnaymneh	C/O H.i.g. Capital 1450 Brickell Avenue, 31St Floor Miami FL 33131	No	No	Yes	No
1173671	Hig Gp Ii Inc	C/O H.i.g. Capital 1450 Brickell Avenue, 31St Floor Miami FL 33131	No	No	Yes	No
1515804	H.i.g. Ventures - Tranzyme, Llc	C/O H.i.g. Capital 1450 Brickell Avenue, 31St Floor Miami FL 33131	No	No	Yes	No
1515825	Aaron Davidson	C/O H.i.g. Capital 1450 Brickell Avenue, 31St Floor Miami FL 33131	Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-04-06	2,189,791	$0.00	2,189,791	No	4	C	Direct
Common Stock	Acquisiton	2011-04-06	812,500	$4.00	3,002,291	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Preferred Stock	Disposition	2011-04-06	15,328,551	$0.00	2,189,791	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct

Footnotes

Each share of the Issuer's Series A Convertible Preferred Stock automatically converted, for no additional consideration, into shares of Common Stock prior to the closing of the Issuer's initial public offering on a 7-for-1 basis, reflecting a 1-for-7 reverse stock split which became effective on March 31, 2011.
These securities are owned of record by H.I.G. Ventures - Tranzyme, LLC ("HIG LLC"). H.I.G. - GPII, Inc. ("GP II") is the manager of HIG LLC and has shared voting and dispositive power of the securities held by HIG LLC, but GP II disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. The co-presidents, directors, and sole shareholders of GP II having shared voting and dispositive power over these securities are Sami Mnaymneh and Anthony Tamer, each of whom disclaims beneficial ownership of such securities except to the extent of his pecuniary interests therein.
These shares were purchased in the Issuer's initial public offering.